EX-99.1 3 d94746ex99-1.txt TEXT OF INVESTOR RELATIONS SLIDE SHOW EXHIBIT 99.1 Amedisys A Healthy Investment for the 21st Century ================================================================================ Statements contained in this presentation which are not historical facts are forward-looking statements. These forward-looking statements and all other statements that may be contained in this presentation that are not historical facts are subject to a number of risks and uncertainties, and actual results may differ materially than those forecasted. Such forward-looking statements are estimates reflecting the best judgment of Amedisys, Inc. management based upon currently available information. Certain factors which could affect the accuracy of such forward-looking statements are identified in the public filings made by Amedisys, Inc. with the Securities and Exchange Commission, and forward-looking statements contained herein, or other public statements of Amedisys, Inc. or its management should be considered in light of those factors. ================================================================================ Amedisys Facts o One of the top 5 U.S. home nursing companies o Profitable in Medicare's Prospective Payment System o Provides skilled nursing care supported with acute care technology o Publicly traded since 1994 ================================================================================ Amedisys Facts Largest Home Care Nursing Company in the South 60 Locations Oklahoma - 5 Louisiana - 5 Alabama - 10 Tennessee - 11 Georgia - 23 Florida - 3 South Carolina - 1 North Carolina - 1 Virginia - 1 ================================================================================ Home Health Care Facts 1800's Home Health Care Begin October 1, 2000 Medicare allows profits 1965 Medicare started coverage 1999 Industry consolidation/closures Home Health Care 1980's Technology goes to the home 1999 $36 Billion industry 1997 Balanced Budget Act changed the rules 1999 20,000 Providers treated 8M people
================================================================================ What is Home Health Care Today? "Medical care delivered to a homebound patient by licensed professionals supervised by the patient's physician." ================================================================================ Amedisys is Positioned in the Largest Industry Segment... Nursing 70% STOCK PRICES Infusion 14% 2-25-02 Respiratory 10% NURSING DME 6% Amedisys $7.00 Gentiva $23.80 Odyssey $28.25 Source: Jeffries & Co. 2001 RESPIRATORY Lincare $25.10 Apria $22.05 INFUSION Option Care $13.10
================================================================================ What Does Amedisys Offer? Care in These Areas... Diabetes Cardiac Orthopedics Cancer Respiratory Neurology Wound Care Post-Surgical Antibiotic Therapy Rehabilitation Pain Mgt. Hydration Malnutrition
================================================================================ Why is Amedisys a Healthy Investment? o AMED is positioned for growth o AMED is profitable o AMED is partnered with industry leaders ================================================================================ Amedisys is Positioned for Growth Growth Drivers Consolidation of Home Health Transition from Facility to Aging of America Industry Non-Facility Care
================================================================================ Amedisys is Positioned for Growth o 26% decrease in companies since BBA 1997 o 30% of Medicare certified agencies are hospital based o Hospitals lost the cost shifting benefit and are divesting o Opportunities for acquisitions at reasonable costs ================================================================================ Amedisys is Positioned for Growth Internal Growth Strategies o Gain market share from agency attrition o Increase referral base with superior DSM programs o Build physician relationships with strong sales force o Develop managed care business External Growth Strategies o Expand service area with quality acquisitions o Valuations of agencies increasing but still attractive ================================================================================ Amedisys is Positioned for Growth
Acquisition History Alliance Home Health January 1998 Oklahoma Precision Home Health April 1998 Louisiana Columbia HCA November 1998 Southern States Northwest Home Health October 2000 Georgia Mid-Florida Home Health November 2000 Florida Seton Home Health Services April 2001 Alabama HealthCalls June 2001 South Carolina Divested Non-Core Assets 1998 - 2001
================================================================================ Amedisys is Positioned for Growth o Health care costs are 14% of the GDP o Home care is a cost effective alternative o Millimann & Robertson - 56-64% of inpatient care is avoidable o Home care reduces the length of hospital stays o Payers encourage home care to preserve margins o 90% of AARP members prefer to be treated at home ================================================================================ Amedisys is Positioned for Growth
National Healthcare Expenditures as a Percentage of GDP 1980 8.8% 1990 12.0% 1993 13.4% 1996 13.3% 1997 13.2% 1998 13.0% 1999 13.0% 2000* 13.1% 2001* 13.4% 2002* 13.9% 2003* 14.3% 2004* 14.6% 2005* 14.9% 2006* 15.1% 2007* 15.3% 2008* 15.5% 2009* 15.7% 2010* 15.9% Source: HCFA Online * Estimated
================================================================================ Amedisys is Positioned for Growth
Average Per Diem Cost Comparison Inpatient Hospital $1,000 Skilled Nursing Facility $500 Home Health Care $90 Source: Jefferies & Co. 2001
================================================================================ Amedisys is Positioned for Growth
Home Healthcare Spending 1980 $2.4 1990 $12.6 1993 $21.9 1996 $33.6 1997 $34.5 1998 $33.5 1999 $33.1 2000* $36.6 2001* $41.3 2002* $46.6 2003* $51.4 2004* $56.4 2005* $61.1 2006* $66.0 2007* $71.2 2008* $76.2 2009* $81.5 2010* $87.0 Dollars in billions * Projected Source: HCFA Online
================================================================================ Amedisys is Positioned for Growth
Pop. 65 yrs. and over. US, 1950 - 2030 1950 1960 1970 1980 1990 2000 2010 2020 2030 85+ 0.6 0.9 1.5 2.2 3.0 4.3 5.7 6.5 8.5 65+ 12.2 16.6 20.1 25.5 31.1 34.7 39.4 53.2 69.4
Source: Health, U.S. 1999, Health and Aging Chartbook, U.S. Health and Human Services Dept. Current patients per 1,000 Population Women Men 65-74 yrs. 27.6 18.2 75-84 yrs. 84.1 55.4 85+ 130.1 99.5
================================================================================ Amedisys is Positioned for Growth
Home Health Services Received By Patients 65 Years of Age and Over Nursing 85.3% Homemaker 28.7% Physical therapy 20.0% Social services 10.9% Medications 9.9% Continuous home care 5.8% Occupational therapy 4.8% MD services 3.7% Nutrition 3.4% Other services 15.1% Source, U.S. 1999, Health and Aging Chartbook, U.S. Health and Human Services Dept.
================================================================================ Amedisys is Profitable o Episode costs are closely monitored o Average episode costs are below episode payments o Treatment protocols direct care, control costs o Technology is creating more efficiency ================================================================================ Amedisys Is Profitable
Prospective Payment System Example: Patient with Diabetes Fixed Rate $2,274 Illness Adj. 740 Wage Index (63) Total Payment Per Episode $2,951 Net Profit $300
================================================================================ Amedisys is Profitable
Financial Performance Revenues 1st Q 01 2nd Q 01 3rd Q 01 4th Q 01 Amounts in millions except Earnings per Share Net Service Revenues $22.1 $27.2 $29.7 $31.1 Operating Income $0.1 $1.8 $2.6 $3.0 Net Income from Continuing $(0.4) $1.2 $2.0 $2.5 Operations (Loss) - Pre-Tax EPS from Continuing Operations $(0.05) $0.15 $0.25 $0.31 (Loss) - Pre-Tax
================================================================================ Amedisys is Profitable
Financial Performance Revenue 4th Q 01 4th Q 00 2001 2000 Amounts in millions except Earnings Per Share Net Service Revenue $31.1 $19.4 $110.2 $88.2 Operating Income $3.0 $(0.1) $7.5 $(2.6) (Loss) Net Income from $2.5 $(0.1) $5.3 $(4.3) Continuing Operations - Pre-Tax EPS from Continuing $0.31 $(0.02) $0.66 $(1.00) Operations - Pre-Tax
================================================================================ Amedisys has a Profitable Growth Strategy
Growth Strategy Going Forward Capitalize on Exploit Trend to Grow with the Industry Non-Facility Aging of America Consolidation Based Care o Patients need more o AMED will expand o AMED will provide a health care as they age Markets with sale force viable solution to the o AMED provides home o AMED will acquire increasing cost of health care - a patient's first hospital based agencies care choice for care
================================================================================ Amedisys is Partnered with Industry Leaders Partners in Wound Care ConvaTec Bristol-Myers Squibb divisions A Bristol-Myers Squibb Company Hill-Rom Mead Johnson A HILLENBRAND INDUSTRY Nutritionals DU PONT DuPont Pharmaceuticals Company ================================================================================ Amedisys is a Healthy Investment Growth Driven by Major Industry and Demographic Trends Profitable in the Partnered with Prospective Payment Industry Leaders System Strengthening Increasing Visibility Financial Position With Nasdaq Listing And Stock Price ================================================================================ Put Amedisys in Your Portfolio The Healthy Investment for the 21st Century